Eculizumab in MPGN II (Membranoproliferative glomerulonephritis type II) - a promising therapy option.

被引：0
作者：
Schalk, Gesa [1 ]
Gessner, Michaela [1 ]
Zipfel, Peter F. [3 ]
Hoppe, Bernd [2 ]
Nuesken, Kai D. [1 ]
Doetsch, Joerg [1 ]
机构：
[1] Univ Hosp Cologne, Cologne, Germany
[2] Univ Hosp Bonn, Cologne, Germany
[3] Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany
来源：
PEDIATRIC NEPHROLOGY | 2013年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1568 / 1568
页数：1
相关论文
共 50 条
  • [21] Multimodal imaging of membranoproliferative glomerulonephritis type II
    Cebeci, Zafer
    Bayraktar, Serife
    Oray, Merih
    Kir, Nur
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2016, 30 (04) : 260 - 263
  • [22] MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN) - MORPHOGENESIS OF THE TYPE-III LESION
    ANDERS, D
    KIDNEY INTERNATIONAL, 1985, 28 (02) : 259 - 259
  • [23] Differences between type I and II membranoproliferative glomerulonephritis
    Andresdottir, M. B.
    Wetzels, J.
    KIDNEY INTERNATIONAL, 2006, 70 (08) : 1526 - 1527
  • [24] Retinal function abnormalities in membranoproliferative glomerulonephritis type II
    Kim, RY
    Faktorovich, EG
    Kuo, CY
    Olson, JL
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (05) : 619 - 628
  • [25] Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II
    Framme, C
    Herboth, T
    Roider, J
    Laqua, H
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1998, 213 (04) : 252 - 253
  • [26] Patient with type II membranoproliferative glomerulonephritis. Intravitreal bevacizumab therapy for horoidal neovascularization
    Karampelas, M.
    Kopsachilis, N.
    Chang, J. H.
    Pal, B.
    OPHTHALMOLOGE, 2012, 109 (08): : 791 - 793
  • [27] Imatinib Therapy for Non-Infection-Related Type II Cryoglobulinemia With Membranoproliferative Glomerulonephritis
    Wallace, Eric
    Fogo, Agnes B.
    Schulman, Gerald
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (01) : 122 - 125
  • [28] Waldenstrom macroglobulinemia presenting as cryoglobulinemic type II membranoproliferative glomerulonephritis
    Anton Vazquez, Vanesa
    Gimenez Torrecilla, Isabel
    Goma Gallego, Montserrat
    Paredes Henao, Viviana
    NEFROLOGIA, 2018, 38 (04): : 439 - 441
  • [29] Membranoproliferative glomerulonephritis type II (dense deposit disease):: An update
    Appel, GB
    Cook, HT
    Hageman, G
    Jennette, JC
    Kashgarian, M
    Kirschfink, M
    Lambris, JD
    Lanning, L
    Lutz, HU
    Meri, S
    Rose, NR
    Salant, DJ
    Sethi, S
    Smith, RJH
    Smoyer, W
    Tully, HF
    Tully, SP
    Walker, P
    Welsh, M
    Würzner, R
    Zipfel, PF
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05): : 1392 - 1403
  • [30] In situ complement activation in porcine membranoproliferative glomerulonephritis type II
    Jansen, JH
    Hogåsen, K
    Harboe, M
    Hovig, T
    KIDNEY INTERNATIONAL, 1998, 53 (02) : 331 - 349
12345